Literature DB >> 17075276

Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture.

Mitsuko Kondo1, Jun Tamaoki, Kiyoshi Takeyama, Kazuo Isono, Kiyomi Kawatani, Takehiro Izumo, Atsushi Nagai.   

Abstract

BACKGROUND: Interleukin (IL)-13 induces goblet cell metaplasia and plays an important role in mucus hypersecretion in asthma. We previously reported that IL-13 induced goblet cell differentiation along with less ciliated cell differentiation in guinea pig tracheal epithelial cells in vitro. In this study, we asked whether elimination of IL-13 could reverse the established goblet cell metaplasia into ciliated epithelia.
METHODS: Primary epithelial cells from guinea pig tracheas were cultured at an air-liquid interface with the medium containing human recombinant IL-13 for 14 days, and continuously cultured with IL-13-eliminated medium, or cultured under the condition of neutralization of IL-13 with anti IL-13 antibody.
RESULTS: 2 days after elimination of IL-13, the periodic acid-Schiff-positive area as well as MUC5AC protein level rapidly decreased. After 4 days, the number of goblet cells dramatically decreased, while that of ciliated cells inversely increased. The total number of epithelial cells did not change, and 5-bromo-2'-deoxyuridine uptake decreased after IL-13 elimination. Transitional cells with cilia and secretory granules increased after IL-13 elimination. Similarly, the neutralization of IL-13 with anti-IL-13 antibody for 5 days reversed the goblet cell metaplasia into ciliated epithelia, and transitional cells also increased.
CONCLUSIONS: Elimination of IL-13 reverses goblet cell metaplasia into ciliated epithelia in vitro, and transition of goblet cells to other phenotypes, especially ciliated cells, may be involved in this phenomenon. IL-13 inhibition may be a therapeutic strategy of established goblet cell metaplasia in asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075276     DOI: 10.2332/allergolint.55.329

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  22 in total

1.  Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Authors:  C S De Paiva; J K Raince; A J McClellan; K P Shanmugam; S B Pangelinan; E A Volpe; R M Corrales; W J Farley; D B Corry; D-Q Li; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-12-22       Impact factor: 7.313

Review 2.  Role of interleukin-13 in asthma.

Authors:  Jonathan Corren
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 3.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Esterified eicosanoids: generation, characterization and function.

Authors:  Victoria J Hammond; Valerie B O'Donnell
Journal:  Biochim Biophys Acta       Date:  2011-12-19

5.  Plasticity of airway epithelial cells.

Authors:  Pedro C Avila
Journal:  J Allergy Clin Immunol       Date:  2011-12       Impact factor: 10.793

6.  IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells.

Authors:  Johanna Tukler Henriksson; Terry G Coursey; David B Corry; Cintia S De Paiva; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

7.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

8.  Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.

Authors:  Marrah E Lachowicz-Scroggins; Homer A Boushey; Walter E Finkbeiner; Jonathan H Widdicombe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

9.  Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells.

Authors:  Jinming Zhao; Ben Maskrey; Silvana Balzar; Kazuyuki Chibana; Anthony Mustovich; Haizhen Hu; John B Trudeau; Valerie O'Donnell; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

Review 10.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.